Keyphrases
Stevens-Johnson Syndrome
100%
Toxic Epidermal Necrolysis
100%
Burn Unit
100%
Stevens-Johnson Syndrome/toxic Epidermal Necrolysis
100%
Mortality Rate
22%
Patient with Burns
22%
Retrospective Review
22%
Corticosteroids
11%
Early Intervention
11%
Multidisciplinary Team
11%
Pathophysiology
11%
Mucosa
11%
Clinical Course
11%
Standard of Care
11%
Clinical Patients
11%
Clinical Treatment
11%
Necrosis
11%
High Mortality Rate
11%
Inclusion Criteria
11%
Significant Predictors
11%
Patient-reported Outcomes
11%
Consecutive Patients
11%
Mortality Factors
11%
Germany
11%
Number of Risk Factors
11%
Burn Center
11%
Epidermis
11%
Cyclosporine
11%
Mortality Prediction
11%
Age of Death
11%
Single Center
11%
Supportive Care
11%
Optimal Treatment
11%
Conflict of Interest
11%
SCORTEN Score
11%
Patient Cohort
11%
Blister
11%
Disease-specific Mortality
11%
High-dose Intravenous Immunoglobulin
11%
Matched Cohort
11%
Adverse Drug Reaction
11%
Age Score
11%
Key Risk Factors
11%
Declare
11%
Declaration of Interest
11%
Skin Hypersensitivity
11%
Medicine and Dentistry
Toxic Epidermal Necrolysis
100%
Stevens-Johnson Syndrome
100%
Burn Unit
100%
Thermal Burn
21%
Mortality Rate
21%
Pathophysiology
7%
Mucosa
7%
Drug Megadose
7%
Necrosis
7%
Disease Course
7%
Allergic Response
7%
Cyclosporine
7%
Skin Allergy
7%
Adverse Drug Reaction
7%
Supportive Care
7%
Early Intervention
7%
Immunosuppressant
7%
Diseases
7%
Primary Outcome
7%
Patient-Reported Outcome
7%
Nursing and Health Professions
Toxic Epidermal Necrolysis
100%
Burn Unit
100%
Stevens Johnson Syndrome
100%
Thermal Burn
21%
Mortality Rate
21%
Pathophysiology
7%
Drug Megadose
7%
Patient-Reported Outcome
7%
Necrosis
7%
Immunosuppressive Agent
7%
Ciclosporin
7%
Early Intervention
7%
Disease Course
7%
Health Care Quality
7%
Allergic Reaction
7%
Adverse Drug Reaction
7%
Skin Allergy
7%
Diseases
7%
Pharmacology, Toxicology and Pharmaceutical Science
Burn
100%
Toxic Epidermal Necrolysis
100%
Stevens Johnson Syndrome
100%
Mortality Rate
21%
Pathophysiology
7%
Disease Course
7%
Immunosuppressive Agent
7%
Necrosis
7%
Allergic Reaction
7%
Ciclosporin
7%
Skin Allergy
7%
Adverse Drug Reaction
7%
Diseases
7%